probiome Sign in
← Conditions Digestive system

Non-alcoholic fatty liver disease

Compared within 1 study that had both: 153 people with non-alcoholic fatty liver disease and 20 healthy people. 1 microbe is less common in people with non-alcoholic fatty liver disease, and 1 more common.

A difference is an association: it doesn’t mean these microbes cause, prevent or treat non-alcoholic fatty liver disease.

Phylum

Searching opens both lists and shows only matching rows.

Less common in non-alcoholic fatty liver disease · 1

Strongest first, then the biggest gap · Each figure is 10 people Strongest first · Each figure is 10 people
  1. Victivallis vadensis in 1 study Healthy 35% non-alcoholic fatty liver disease 6.5%

More common in non-alcoholic fatty liver disease · 1

Strongest first, then the biggest gap · Each figure is 10 people Strongest first · Each figure is 10 people
  1. Eggerthella lenta in 1 study Healthy 0% non-alcoholic fatty liver disease 41%

Where these numbers come from

Studies
Only GMrepo projects that had people with the condition and healthy people, 10 or more of each. Numbers come from those studies, never from pooling.Sampled in France.
How common
The share of people whose sample has any of it, in the people with the condition and in the healthy people of those same studies. Tested within studies (Cochran–Mantel–Haenszel, corrected for testing many microbes); a difference counts when it is clear and meaningful (Cohen’s h of 0.2 or more).
Strength word
Counted by code from how many studies point the same way: Seen again and again (3 or more, none clearly the other way), Seen more than once (2, the majority), Seen once (1, listed last). Where studies disagree, a row isn’t listed.
Each study
Tap a row for every study’s own numbers, and for how much carriers have.
Analysis
Our analysis of GMrepo data. GMrepo on Data sources · Read the rules

Also compared · 339 microbes

Compared within studies that had both, but not listed above.

No meaningful difference · 339
PubMed · human studies and reviews first

Recent research

All research on it
  1. Review FASEB journal · 2026
    The Gut-Liver Axis in Metabolic Dysfunction-Associated Steatotic Liver Disease: From Mechanistic Insights to Precision Therapeutics.
    PubMed ↗
  2. Systematic review Current obesity reports · 2026
    The Role of Butyrate in People with Metabolic Dysfunction-Associated Steatotic Liver Disease and Related Metabolic Comorbidities: A Systematic Review.
    PubMed ↗
  3. Observational BMC microbiology · 2025
    High alcohol-producing Escherichia coli causes obesity and steatotic liver disease in a non-alcoholic cohort -a preclinical study.
    PubMed ↗
  4. Systematic review BMC gastroenterology · 2025
    Therapeutic potential of Akkermansia muciniphila in non-alcoholic fatty liver disease: a systematic review.
    PubMed ↗
  5. Randomized trial Journal of agricultural and food chemistry · 2025
    Hydroxytyrosol Improves Metabolic Dysfunction-Associated Fatty Liver Disease Dependent on the Modulation of Gut Microbiota.
    PubMed ↗

Source: PubMed, U.S. National Library of Medicine · 171 linked papers, last 10 years